Medtech Limited v Valentia Technologies (NZ) Limited

Link copied
Case Copied 15 min read

IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY

I TE KŌTI MATUA O AOTEAROA TĀMAKI MAKAURAU ROHE

CIV-2023-404-003051

[2025] NZHC 913

BETWEEN

MEDTECH LIMITED

Plaintiff

AND

VALENTIA TECHNOLOGIES (NZ) LIMITED

Defendant

Hearing: 6 March 2025

Appearances:

A Ross KC and O Sutton for Plaintiff

K T Glover and D T D Horton for Defendant

Judgment:

15 April 2025


JUDGMENT OF ANDERSON J


This judgment was delivered by me on 15 April 2025 at 11.00 am pursuant to r 11.5 of the High Court Rules 2016.

………………………………

Registrar/Deputy Registrar

Solicitors:Minter Ellison Rudd Watts, Auckland Create IP, Auckland

MEDTECH LTD v VALENTIA TECHNOLOGIES (NZ) LTD [2025] NZHC 913 [15 April 2025]

[1]        The plaintiff, Medtech, seeks leave to appeal two of my interlocutory judgments:1

(a)a judgment rescinding preservation orders dated 20 June 2024 (the Preservation Orders Judgment);2

(b)a costs order  relating  to  the  Preservation  Orders  Judgment  dated  8 November 2024 (the Costs Judgment).3

[2]        Medtech also seeks an extension of time in which to apply for leave to appeal the Preservation Orders Judgment. I grant an extension so that the leave issue can be dealt with directly.

[3]        The applications are unusual. The gist of Medtech’s application is that in the Cost Judgment I concluded that Valentia was the successful party on the Preservation Orders Judgment when I should not have done. Medtech says this finding was in “error” because I had been misled by Valentia’s affidavit evidence to conclude in the Preservation  Orders Judgment that without-notice preservation orders  I  made on  21 December 2024 (Preservation Orders) should not have been made.

[4]For the reasons outlined below, I dismiss the applications for leave to appeal.

Relevant procedural background

[5]        The parties are competitors in the provision of patient/practice management software to medical practices (PMS). PMS is used for patient record-keeping and practice management at GP office practices and other health care providers. Medtech’s products are Medtech32 and a more recent product, Medtech Evolution. Valentia’s product is called indici. Medtech currently has 70 per cent of the market. Valentia has 17 per cent.


1      Pursuant to s 56(3) of the Senior Courts Act 2016, leave is required to pursue the interlocutory appeals.

2      Medtech Ltd v Valentia Technologies (NZ) Ltd [2024] NZHC 1618 (Preservation Orders Judgment).

3      Medtech Ltd v Valentia Technologies (NZ) Ltd [2024] NZHC 3315.

[6]        On 19 December 2023, Medtech issued proceedings against Valentia alleging breaches of intellectual property rights, interference with contractual relations, breach of confidence, breach of a settlement of earlier litigation, and misleading conduct under the Fair Trading Act 1986. Medtech sought a range of interim orders without notice,  including  the  Preservation  Orders  I  made   on   21   December   2024.4 The Preservation Orders were aimed at preserving a snapshot of the present version of Valentia’s software, associated intellectual property and operating environment so that Medtech could assess whether there had been a breach of its rights.

[7]        In June 2024, I rescinded the Preservation Orders in the Preservation Orders Judgment. I also made orders for discovery…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Medtech Limited v Valentia Technologies (NZ) Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2025] NZHC 913
Decision Date

CaseChat Overview and Summary

Medtech Limited, a provider of patient/practice management software, sought leave to appeal two interlocutory judgments from the High Court in Auckland: a judgment rescinding preservation orders and a costs order related to that judgment. The plaintiff, Medtech, argued that the judge had been misled by the defendant, Valentia Technologies (NZ) Limited, resulting in an incorrect finding in the Preservation Orders Judgment. Medtech contended that the misleading information should not allow the costs award in the Costs Judgment to stand. The court considered whether the alleged error was of sufficient importance to warrant an appeal and whether the interests of justice would be served by granting leave.

The court found that Medtech's application was unusual, as it did not seek to challenge the outcome of the Preservation Orders Judgment but rather the reasons for it. The judge concluded that the application was more suited to a recall procedure than an appeal, as it sought to challenge the reasons for the judgment rather than the judgment itself. The judge further held that even if leave to appeal was appropriate, a strong factual platform was required to demonstrate that the court had been misled with material effect. The judge was not sufficiently persuaded that the court had been misled, as the inconsistencies in the affidavits provided by Valentia did not undermine the overall conclusions reached in the Preservation Orders Judgment.

The court dismissed the applications for leave to appeal and ordered costs in favour of Valentia on a 3B basis, meaning the costs would be paid by Medtech. The court found that the appeal would not serve the interests of justice and would be a waste of limited appellate court resources.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.